Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01044927 · ClinicalTrials.gov registry record · Phase 3

Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado

A Phase 3 study, sponsored by University of Colorado, Denver.

Completed
Registry status
Phase 3
Development phase
511
Enrollment target

NCT01044927: Completed Phase 3 study, sponsored by University of Colorado, Denver.

NCT01044927 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 511 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01044927, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
Phase 3
Development phase
511 participants
Enrollment target

Study Summary

Chronic obstructive pulmonary disease (COPD) is the 4th leading cause of death in the United States, affects 24 million people and is responsible for up to $32 billion annually in direct and indirect health care costs. Based upon these national COPD prevalence data, we estimate that 483,000 Coloradans have COPD (193,000 diagnosed and 290,000 undiagnosed), and that the care of these patients costs up to $490 million annually. Therefore, to alter the impact of COPD on the State and People of Colorado, we propose to introduce a telephone-dependent, internet-supported, self-monitoring "eHealth" management system in both urban and rural Colorado settings in order to decrease healthcare utilization, improve the management of COPD based upon current national guidelines, improve quality of life, reduce health care costs decrease COPD exacerbations. We base this program on a successful clinical pilot study, performed at the University of Colorado Hospital (UCH) during 2004-2005, which demonstrated dramatic improvements in quality of life and decreased health care costs. We propose to enroll patients with advanced COPD, or a history of COPD exacerbations, because these are the patients with the highest healthcare costs, the greatest disability, and the highest mortality. The ultimate goal of this project is to demonstrate the feasibility and efficacy of this proactive management strategy as it is disseminated throughout urban and rural Colorado. In this first phase we will target two Denver Metro sites, UCH and Kaiser-Permanente (KP), and rural sites (to be determined). We chose these urban sites because of their strong interest in enacting the eHealth Program, because of their organized systems of healthcare delivery and because of the numbers of COPD patients that they serve. We are particularly enthusiastic about the application of this technology to rural, underserved areas, because this approach has the potential to dramatically improve delivery of healthcare to a large

Interventions

  • OTHER Standard Therapy
  • OTHER Integrated Care

Trial Details

FieldValue
Enrollment Target 511 participants
Start Date 2006-09
Est. Completion 2008-06
Phase Phase 3
University of Colorado, Denver

1,283 total trials

What the finished NCT01044927 record still lists

NCT01044927 is an interventional study that assigns participants to a tested intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Therapy is the first listed.

NCT01044927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01044927 about?

NCT01044927 is a clinical study titled "Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado". Chronic obstructive pulmonary disease (COPD) is the 4th leading cause of death in the United States, affects 24 million people and is responsible for up to $32 billion annually in direct and indirect health care costs. Based upon these national COPD prevalence data, we estimate that 483,000 Colorada...

What is the current status of trial NCT01044927?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 511 participants. The study started on 2006-09. Estimated completion is 2008-06.

What interventions are being tested in trial NCT01044927?

The interventions under investigation include: Standard Therapy (OTHER), Integrated Care (OTHER).

Who is sponsoring clinical trial NCT01044927?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01044927's enrollment target sits among peer trials

511 728th of 2000 higher than 1,272 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05005403 · 512 participants · Phase 1

    Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

  • NCT05337410 · 512 participants · NA

    YES: Innovative Discussion for Engagement, Achievement, and Service

  • NCT06096259 · 512 participants · Phase 2

    Preventing Injured Knees From osteoArthritis: Severity Outcomes

  • NCT03922542 · 510 participants · Phase 2

    Comparison of Standard vs. Accelerated Corneal Crosslinking

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01044927, the US trial registry maintained by the National Library of Medicine. NCT01044927 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.